View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

NHN Entertainment Corp: 1 director

A director at NHN Entertainment Corp bought 1,000,000 shares at 22,750.000KRW and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Edison issues update on Henderson Far East Income (HFEL): Repositionin...

Edison Investment Research Limited Edison issues update on Henderson Far East Income (HFEL): Repositioning to raise total returns 25-Apr-2024 / 12:25 GMT/BST The issuer is solely responsible for the content of this announcement.   London, UK, 25 April 2024   Edison issues update on Henderson Far East Income (HFEL): Repositioning to raise total returns Henderson Far East Income (HFEL) has consistently delivered on its objective to provide a rising dividend. However, like many investors, HFEL’s managers overestimated the potential for a post-pandemic rebound in China. The trust...

SP New Energy Corporation: 2 directors

Two Directors at SP New Energy Corporation bought 5,000,000 shares at 1.000PHP. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...

 PRESS RELEASE

ParaZero Integrates its Safety Technology into Draganfly’s Commander 3...

ParaZero Integrates its Safety Technology into Draganfly’s Commander 3XL Drones for Home Hospital Delivery and Emergency Response Tel Aviv, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "Company” or “ParaZero”), an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, today announced a strategic collaboration with Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly”), an industry pioneer in commercial drone technology, integrating its advanced safety technology into Draganfly’s C...

Jayanth Kandalam
  • Jayanth Kandalam

Italmatch Chemicals - Earnings Flash - FY 2023 Results - Lucror Analyt...

Italmatch Chemicals has reported weak FY 2023 numbers. That said, we view the results as robust when taking into account the challenging macroeconomic environment. While the absolute contribution margin and adjusted EBITDA declined y-o-y, the unit contribution margin increased, reflecting a preference for margins over volumes. EBITDA margins were only slightly below prior-year levels, which evidenced good execution of cost-saving initiatives. Cash-flow development was a highlight, with Italmatch...

 PRESS RELEASE

Draganfly Integrates ParaZero Safety Technology into Commander 3XL Dro...

Draganfly Integrates ParaZero Safety Technology into Commander 3XL Drones for Home Hospital Delivery and Emergency Response San Diego, CA., April 25, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., (NASDAQ: PRZO) a pioneer in drone safety systems aimed at enhancing the safety and efficacy of UAVs in medical and emergency response operations. The integration of Draganfly and...

Zhengwei Group Holdings Company Limited: 1 director

A director at Zhengwei Group Holdings Company Limited sold 13,384,000 shares at 0.218HKD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...

Biokarpet S.A: 3 directors

Three Directors at Biokarpet S.A sold 300,000 shares at 2.740EUR. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

NGS Group AB (publ): Delårsrapport januari-mars 2024

NGS Group AB (publ): Delårsrapport januari-mars 2024 Paradigmskifte inom sjuksköterskebemanning i Sverige. Full kraft i Norgeexpansion. Beslut om nyemissioner.      Första kvartalet i sammandrag Nettoomsättningen för första kvartalet uppgick till 100 MSEK (141), en minskning med 29%.Rörelseresultatet (EBITDA) för första kvartalet upp­gick till -5,5 MSEK (-1,6), rörelse­marginal -5,5% (-1,1).Rörelseresultatet (EBIT) för första kvartalet upp­gick till -6,8 MSEK (-2,7), rörelse­marginal -6,8% (-1,9).Resultatet för första kvartalet uppgick till -6,3 MSEK (-2,8).Resultatet per aktie före och...

Felix Fischer
  • Felix Fischer

Lucror Analytics - Morning Views Latam

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit

 PRESS RELEASE

Altisource Announces First Quarter 2024 Financial Results

Altisource Announces First Quarter 2024 Financial Results LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the first quarter 2024. “I am very pleased with our first quarter performance. We generated $4.6 million of Adjusted EBITDA(1), marking our best quarterly performance since the third quarter of 2020, on $36.9 million of service revenue. We are winning meaningful new business and ramping ...

 PRESS RELEASE

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in ...

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback HB-200 accepted for oral abstract presentation at ASCO 2024 Annual Meeting with data from approximately 40 patients treated with HB-200 in combination with pembrolizumab Two additional abstracts for HB-200 and HB-700 accepted for the ASCO 2024 Annual Meeting Company to host investor call at 8:0...

 PRESS RELEASE

Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share

Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company's outstanding common stock, a 9% increase from the previous quarter. The dividend is payable on June 28, 2024 to shareholders of record at the close of business on June 14, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About Nasdaq N...

Simon Strong
  • Simon Strong

Excellent momentum in new orders

Corero has secured $8m of orders from both existing and new customers in the first four months of FY24E. The group reported a 17% YoY growth rate in annualised recurring revenue (ARR) last year. This level of momentum in orders not only supports our double-digit % growth forecasts, but also validates the Group’s go-to-market strategy. We are forecasting +13% growth in revenues in FY24E to $25.3m (unchanged), With gross margins high at 90%, the drop through rate of incremental revenues to earnin...

 PRESS RELEASE

Valley National Bancorp Announces First Quarter 2024 Results

Valley National Bancorp Announces First Quarter 2024 Results NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the first quarter 2024 of $96.3 million, or $0.18 per diluted common share, as compared to the fourth quarter 2023 net income of $71.6 million, or $0.13 per diluted common share, and net income of $146.6 million, or $0.28 per diluted common share, for the first quarter 2023. Excluding all non-core income and charges, our adjusted net income (a non-GAAP measure) was $99.4 m...

Luk Fook Holdings (International) Ltd: 1 director

A director at Luk Fook Holdings (International) Ltd bought 600,000 shares at 17.957HKD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

 PRESS RELEASE

Morphic Announces Corporate Highlights and Financial Results for the F...

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 - Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 study of MORF-057 in patients with moderate-to-severe Crohn’s disease in second quarter- -Ended first quarter with $658.8 million in cash, cash equivalents, and marketable securities; cash runway into second half of 2027- WALTHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- (Na...

 PRESS RELEASE

Connectone Bancorp, Inc. Reports First Quarter 2024 Results; Declares ...

Connectone Bancorp, Inc. Reports First Quarter 2024 Results; Declares Preferred and Increased Common Dividends ENGLEWOOD CLIFFS. N.J., April 25, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $15.7 million for the first quarter of 2024 compared with $17.8 million for the fourth quarter of 2023 and $23.4 million for the first quarter of 2023. Diluted earnings per share were $0.41 for the first quarter of 2024 compared with $0.46 fo...

 PRESS RELEASE

Altria Reports 2024 First-Quarter Results; Reaffirms Full-Year Guidanc...

RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (NYSE: MO) today reports our 2024 first-quarter business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). “We made meaningful progress in pursuit of our Vision, and our highly profitable traditional tobacco businesses continued to perform well in a challenging environment,” said Billy Gifford, Altria’s Chief Executive Officer. “In spite of the absence of an effective regulatory environment, we saw continued early momentum from NJOY and believe our businesses are on track to deliver against ful...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch